Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Potent antitumor agents described by Daiichi

Jan. 15, 1997

Antifungal agent described by Roussel Morishita

Jan. 15, 1997

Japanese scientists report cholecystokinin antagonists

Jan. 15, 1997

Pharmacia & Upjohn describes HIV reverse transcriptase inhibitors

Jan. 15, 1997

Amgen discloses novel eck receptor ligands

Jan. 14, 1997

Genetics Institute reports new bone morphogenic protein

Jan. 14, 1997

Kao discloses cell adhesion inhibitors

Jan. 14, 1997

Thomas Jefferson University claims new apoptotic cysteine protease

Jan. 14, 1997

cGMP PDE inhibitors from Taisho

Jan. 14, 1997

Nitric oxide synthase inhibitors reported by Searle

Jan. 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...